Fresenius SE & Co. KGaA buy Akuma
Summary
This prediction ended on 10.12.19 with a price of €49.05. With a performance of 9.59%, the BUY prediction by Akuma for Fresenius SE & Co. KGaA closed with a slight gain. Akuma has 50% into this predictionFresenius is a German healthcare company listed on the Frankfurt and New York stock exchanges under the symbol FSNUF. The company is primarily engaged in the production and distribution of medical devices, pharmaceuticals, and services related to renal dialysis, critical care, and hospital operations. With over 290,000 employees and operations in more than 100 countries, Fresenius is one of the largest healthcare providers in the world. The company has experienced steady growth over the years, driven by its innovative product portfolio, strategic acquisitions, and a focus on operational efficiency.
Performance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Fresenius SE & Co. KGaA | 3.199% | 3.199% | 16.724% | -16.105% |
iShares Core DAX® | 1.164% | 1.549% | 24.351% | 23.659% |
iShares Nasdaq 100 | 0.118% | 0.969% | 28.865% | 41.786% |
iShares Nikkei 225® | 1.124% | -1.120% | 17.443% | 6.454% |
iShares S&P 500 | 0.479% | 1.068% | 28.585% | 42.511% |
Comments by Akuma for this prediction
In the thread Fresenius SE & Co. KGaA diskutieren
Stopped prediction by Akuma for Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA
27.11.23
27.11.24
09.12.23
Fresenius SE & Co. KGaA
28.06.22
28.06.23
09.07.22
Fresenius SE & Co. KGaA
20.09.21
20.09.22
02.10.21
Fresenius SE & Co. KGaA
11.02.20
22.02.20
22.02.20